Zebinix non-inferior to current standard of care in epilepsy
Eisai and Bial’s epilepsy drug Zebinix has shown effectiveness on par with that of the current standard of care in newly diagnosed focal epilepsy patients.
Read More
Tag: carbamazepine
US clears Lundbeck’s IV epilepsy drug Carnexiv
US regulators have approved Lundbeck’s Carnexiv, the first intravenous formulation of epilepsy drug carbamazepine.
Read More
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
